ACHE and Alzheimer disease: Five drugs have received FDA approval for AD treatment, including the N-methyl-D-aspartate (NMDA) receptor antagonist memantine and acetylcholinesterase inhibitors (AChEIs) such as tacrine, rivastigmine, donepezil, and galantamine.